NAPROSYN

This brand name is authorized in Australia, Canada, Ecuador, Estonia, Spain, Ireland, Italy, Malta, New Zealand, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug NAPROSYN contains one active pharmaceutical ingredient (API):

1 Naproxen UNII 57Y76R9ATQ - NAPROXEN

Naproxen is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties as has been demonstrated in classical animal test systems. Naproxen exhibits its anti-inflammatory effect even in adrenalectomised animals, indicating that its action is not mediated through the pituitary-adrenal axis. Read about Naproxen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NAPROSYN Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M01AE02	Naproxen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE02
M02AA12	Naproxen	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1614Y, 1615B, 1674D, 5176K, 5178M, 5179N, 5345H, 5347K, 5348L
Country: CA	Health Products and Food Branch	Identifier(s): 02162415, 02162423, 02162466
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 5.413-4-01-12
Country: EE	Ravimiamet	Identifier(s): 1243336, 1747728, 1774188, 1774874
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 56267
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 18353, 18407
Country: IE	Health Products Regulatory Authority	Identifier(s): 37157, 37169
Country: IT	Agenzia del Farmaco	Identifier(s): 023177138, 023177189, 023177215
Country: MT	Medicines Authority	Identifier(s): AA1067/00101
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1924, 1925
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699514030577, 8699514037491, 8699514040002, 8699514130123, 8699514340089, 8699514890058
Country: US	FDA, National Drug Code	Identifier(s): 0121-0899, 0121-1798, 0121-2697, 69437-316, 71511-701, 80425-0048, 80425-0049, 80425-0050, 80425-0051
Country: ZA	Health Products Regulatory Authority	Identifier(s): 27/3.1/0067